About 9 results found for searched term "2-NP" (0.054 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2306 | Tideglusib | GSK-3 |
| NP-12; NP031112 | ||
| Tideglusib (NP031112, NP-12) is a potent non ATP-competitive inhibitor of GSK3 with IC50 of 60 nM. | ||
| M7952 | 2-NP | STAT |
| 2NP | ||
| 2-NP is a selective STAT1 transcription enhancer. 2-NP can enhance the ability of IFN-γ to inhibit the proliferation of human breast cancer and fibrosarcoma cells. | ||
| M14643 | 2OH-BNPP1 | Others |
| 2OH-BNPP1 is an inhibitor of BUB1 kinase, a Ser/Thr kinase, used for the treatment of cancer. | ||
| M14779 | Talaporfin sodium | Others |
| ME2906; Mono-L-aspartyl chlorin e6; NPe6 | ||
| Talaporfin (ME2906; NPe6) is a photosensitizer used in photodynamic therapy (PDT). | ||
| M20859 | AUNP-12 | PD-1/PD-L1 |
| Aur-012, Aurigene-012, Aurigene NP-12 | ||
| AUNP-12, a new immune checkpoint modulator, is an inhibitor of the PD-1 pathway. | ||
| M24958 | Peginterferon alfa-2b | HIV Protease |
| PegIFN a-2b; Sch 54031; Sylatron; ViraferonPeg | ||
| Peginterferon alfa-2b (Sch 54031) is an immunomodulator. Peginterferon alfa-2b is a recombinant alfa-2b interferon covalently linked PEG. Peginterferon alfa-2b in decreasing viral DNA in HIV. Peginterferon alfa-2b can be used in research of melanoma. | ||
| M55639 | 2-NP-AOZ | Others |
| 2-NP-AOZ is a 2-nitrophenyl derivative of the tissue-bound metabolite, 3-amino-2-oxazolidinone (AOZ). 2-NP-AOZ may be used as a reference standard for the determination of 2-NP-AOZ in aquatic animals using enzyme linked immunosorbent assay (ELISA). | ||
| M55710 | Mal-amido-PEG2-Val-Cit-PAB-PNP | ADC Linker |
| Mal-amido-PEG2-Val-Cit-PAB-PNP is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | ||
| M58046 | 2-(4-pinacolatoboronphenyl)-3,3-diphenylacrylonitrile | Others |
| 2-(4-pinacolatoboronphenyl)-3,3-diphenylacrylonitrile | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
